Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
about
Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinomaCancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles.MAGE-A Antigens and Cancer Immunotherapy.MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.Melanoma-associated antigen expression and the efficacy of tyrosine kinase inhibitors in head and neck cancer.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neckExpression of MAGE-A1, -A9, -A11 in laryngeal squamous cell carcinoma and their prognostic significance: a retrospective clinical study.Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinomaDownregulation of MAGE family member H1 enhances hepatocellular carcinoma progression and serves as a biomarker for patient prognosis.Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.Cancer-testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non-uterine leiomyosarcoma.Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients.MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1.NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.Antibody response against cancer-testis antigens MAGEA4 and MAGEA10 in patients with melanoma.MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.Cancer/testis antigens (CTAs) expression in resected lung cancer
P2860
Q33599094-718D1038-F6D2-483F-9D4E-28377CFEB702Q35740912-65E60FDC-B835-4D86-9341-CFAC2E0B7665Q37082518-6FCDB113-1816-498B-B1C2-A7F692E068D9Q37222100-23754931-2A1F-4ADA-94C5-F60A0BA3A54AQ37685379-6E66D1BC-1CA1-449F-A2B0-ECB1688A6F84Q37716427-04BD34F9-FB7B-4A02-8DEA-2A875155E97CQ38445350-B145B63B-F80C-4127-BC0D-4C3D1FDE1648Q38815481-B59AA6B2-96EB-4319-A169-B3CCA2CC1024Q38948541-DB47C212-4DF3-47AC-BEDD-12F69868CE2DQ39999283-4EED436F-C842-4D3D-A7B0-D015F2A50BFBQ40977475-17ED4BD9-09E8-45E3-B2D0-B4723F80F739Q41198162-308EA815-751E-4379-977C-EE774D71A8ABQ47742620-14358BF6-7087-46D1-8E5B-89B0480DFEFDQ48334085-0F7C46A9-F5E9-4336-BF88-4B2057051FF1Q49335269-8FAC7A41-6CB9-4017-B242-5643C6A7B337Q52800577-670D75B6-DF4D-41EF-821B-8312BEDA85ADQ54489272-00A82F6D-8DCF-49A5-93C7-AF33CED3C942Q54945263-C9B35EAC-CA2E-4C84-99DB-0805B79B5BB0Q55241840-F1C4FA50-8D64-406F-9EF4-E52DE7FBD18FQ55242409-3CD1AE88-4E9C-4CBF-89A9-24150671AE74Q58806299-98A6F936-74B4-4DF7-AC30-C94880FF377D
P2860
Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Simultaneous cytoplasmic and n ...... vival in head and neck cancer.
@en
Simultaneous cytoplasmic and n ...... vival in head and neck cancer.
@nl
type
label
Simultaneous cytoplasmic and n ...... vival in head and neck cancer.
@en
Simultaneous cytoplasmic and n ...... vival in head and neck cancer.
@nl
prefLabel
Simultaneous cytoplasmic and n ...... vival in head and neck cancer.
@en
Simultaneous cytoplasmic and n ...... vival in head and neck cancer.
@nl
P2093
P2860
P356
P1476
Simultaneous cytoplasmic and n ...... vival in head and neck cancer.
@en
P2093
Alexander Knuth
Chia-Jung Busch
Djordje Atanackovic
Gerd Ritter
Giulio Spagnoli
Guido Sauter
Kerstin Borgmann
Marco Blessmann
Marcus Freytag
Rainald Knecht
P2860
P304
P356
10.1002/IJC.28752
P577
2014-02-11T00:00:00Z